#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3879985	B	Inhibition of human KV1.5 expressed in HEK cells by patch clamp method	Homo sapiens	5	ALA3879887	cell-based format	Patent Bioactivity Data
2.	ALA3879990	B	Inhibition of human KV4.2 expressed in HEK cells by patch clamp method	Homo sapiens	5	ALA3879887	cell-based format	Patent Bioactivity Data
3.	ALA3879991	B	Inhibition of human H1 Na+ channel expressed in HEK cells by patch clamp method	Homo sapiens	5	ALA3879887	cell-based format	Patent Bioactivity Data
4.	ALA3879992	T	Neurotoxicity in iv dosed Sprague-Dawley rat assessed as minimum infusion rate of the compound require for partial and complete convulsion	Rattus norvegicus	45	ALA3879887	organism-based format	Patent Bioactivity Data
5.	ALA3879993	T	Neurotoxicity in iv dosed Sprague-Dawley rat assessed as total amount of drug infused at the point that partial or complete convulsions are first observed	Rattus norvegicus	45	ALA3879887	organism-based format	Patent Bioactivity Data
6.	ALA3879994	F	Antiarrhythmic activity in iv dosed Sprague-Dawley rat coronary artery occlusion model administered via infusion for 5 mins starting 15 post surgery followed by coronary artery occlusion measured for 15 mins by electrocardiogram	Rattus norvegicus	45	ALA3879887	organism-based format	Patent Bioactivity Data
7.	ALA3879995	A	Therapeutic index, ratio of neurotoxicity in iv dosed Sprague-Dawley rat assessed as total amount of drug infused at the point that partial or complete convulsions are first observed to 20 times ED50 for antiarrhythmic activity in iv dosed Sprague-Dawley rat coronary artery occlusion model	Rattus norvegicus	45	ALA3879887	organism-based format	Patent Bioactivity Data